DNM1L and cervical cancer: Our results showed that Drp1-knockdown in cervical cancer cells reduced the G2/M cell cycle arrest (Figure 8A) and reversed the reduction of CDK1, cyclin B1 and cdc25C expressions compared to control cells upon SB treatment (Figure 8B).